Stock listing

ASX:CMP Compumedics Limited Share Price

Follow Compumedics Limited into a list and get an email when it puts out news.

Share price · ASX:CMP

$0.235 AUD 0.000 (0.0%)

Close on Nov 20, 2026

Past year -28.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.225 – $0.235 AUDNov 20, 2026
Volume
69,144 sharesNov 20, 2026
Market cap
$46.94M AUDAt the close on Nov 20, 2026 · price × 199.8M shares outstanding
52-week range
$0.215 – $0.450 AUDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$14,026 AUDMedian day 25,000 shares · 11 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Compumedics Limited logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · ASX:CMP · AUD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.2350.0000.0%$0.230$0.235$0.22569,144
$0.235-0.005-2.1%$0.235$0.235$0.23574,147
$0.2400.0000.0%$0.240$0.240$0.2400
$0.240+0.005+2.1%$0.240$0.240$0.23524,126
$0.235-0.010-4.1%$0.240$0.240$0.23519,300
$0.245+0.005+2.1%$0.245$0.245$0.2454,081
$0.240-0.010-4.0%$0.245$0.245$0.24013,700
$0.250+0.010+4.2%$0.245$0.250$0.24520,990
$0.240+0.005+2.1%$0.245$0.250$0.240135,000
$0.235-0.005-2.1%$0.235$0.235$0.2357,300
$0.240+0.010+4.3%$0.235$0.240$0.23040,588
$0.2300.0000.0%$0.225$0.230$0.2259,000
$0.230-0.005-2.1%$0.230$0.230$0.2302,460
$0.235+0.015+6.8%$0.230$0.235$0.2307,000
$0.220-0.020-8.3%$0.230$0.230$0.220194,352
$0.240+0.005+2.1%$0.230$0.240$0.2303,250
$0.235+0.005+2.2%$0.235$0.235$0.2353,823
$0.2300.0000.0%$0.230$0.230$0.2305,000
$0.2300.0000.0%$0.230$0.230$0.2300
$0.230-0.010-4.2%$0.235$0.235$0.230121,523
$0.2400.0000.0%$0.240$0.240$0.24070,185
$0.240-0.010-4.0%$0.250$0.250$0.2406,350
$0.250+0.005+2.0%$0.250$0.250$0.250127,536
$0.245+0.005+2.1%$0.245$0.245$0.2454,040
$0.2400.0000.0%$0.240$0.240$0.2400
$0.2400.0000.0%$0.240$0.240$0.2400
$0.2400.0000.0%$0.240$0.240$0.2400
$0.2400.0000.0%$0.240$0.240$0.2400
$0.240-0.005-2.0%$0.245$0.245$0.24073,342
$0.2450.0000.0%$0.245$0.245$0.2450
$0.245-0.015-5.8%$0.250$0.250$0.245203,803
$0.2600.0000.0%$0.260$0.260$0.2600
$0.2600.0000.0%$0.263$0.263$0.26028,121
$0.2600.0000.0%$0.260$0.260$0.25542,345
$0.2600.0000.0%$0.265$0.275$0.26061,538
$0.260+0.020+8.3%$0.250$0.260$0.250123,300
$0.2400.0000.0%$0.240$0.240$0.2405,000
$0.240+0.010+4.3%$0.240$0.240$0.24012,477
$0.230-0.010-4.2%$0.230$0.230$0.23025,000
$0.2400.0000.0%$0.240$0.240$0.2400
$0.2400.0000.0%$0.240$0.240$0.24011,398
$0.2400.0000.0%$0.240$0.240$0.24085,058
$0.2400.0000.0%$0.233$0.240$0.22543,916
$0.240-0.010-4.0%$0.230$0.250$0.230107,207
$0.250+0.015+6.4%$0.230$0.250$0.23095,977
$0.235+0.005+2.2%$0.235$0.235$0.2354,255
$0.230-0.005-2.1%$0.230$0.230$0.2302,000
$0.235-0.040-14.5%$0.240$0.240$0.23546,583
$0.2750.0000.0%$0.275$0.275$0.2750
$0.275+0.050+22.2%$0.230$0.275$0.22567,296
$0.225-0.005-2.2%$0.225$0.225$0.22580,604
$0.230-0.003-1.1%$0.230$0.240$0.23090,333
$0.233-0.007-3.1%$0.235$0.235$0.230124,099
$0.240-0.010-4.0%$0.240$0.240$0.2402,000
$0.2500.0000.0%$0.250$0.250$0.2502,268
$0.250+0.015+6.4%$0.235$0.250$0.225253,945
$0.235-0.040-14.5%$0.235$0.235$0.235516
$0.275+0.020+7.8%$0.245$0.275$0.235113,560
$0.2550.0000.0%$0.240$0.270$0.24027,736
$0.2550.0000.0%$0.255$0.255$0.240168,340
$0.2550.0000.0%$0.255$0.255$0.25547,100
$0.255-0.010-3.8%$0.240$0.255$0.24099,849
$0.2650.0000.0%$0.265$0.265$0.2650
$0.2650.0000.0%$0.270$0.270$0.240370,702
$0.265+0.030+12.8%$0.240$0.270$0.240343,812
$0.235+0.005+2.2%$0.230$0.235$0.23025,718
$0.2300.0000.0%$0.235$0.235$0.22537,326
Ticker
ASX:CMP
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
ASX
Currency
AUD

What changed lately

Latest news

Investor Update Nov-26

Nov 10, 2026

Closed $0.25 (+4.2%) on Nov 11, 2026

Appointment of Strategic Advisor

Nov 5, 2026

Closed $0.24 (+4.3%) on Nov 6, 2026

Results of Meeting

Oct 29, 2026

Closed $0.235 (+2.2%) on Oct 29, 2026

Chair's Address to Shareholders

Oct 28, 2026

Closed $0.235 (+2.2%) on Oct 29, 2026

Appendix 4G

Oct 1, 2026

Closed $0.24 (0.0%) on Oct 1, 2026

Corporate Governance Statement

Oct 1, 2026

Closed $0.24 (0.0%) on Oct 1, 2026

Proxy Form

Oct 1, 2026

Closed $0.24 (0.0%) on Oct 1, 2026

Notice of Annual General Meeting

Oct 1, 2026

Closed $0.24 (0.0%) on Oct 1, 2026

Investor Presentation

Sep 29, 2026

Closed $0.24 (+4.3%) on Sep 30, 2026

All Compumedics Limited news

Compumedics Limited on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
18 in the last 12 months · 138 in all · newest Nov 10, 2026 · oldest 2016
Decks
57 decks · latest Nov 11, 2026

Valuation

EV/sales 1.1× against a median of 1.0×: 7th lowest of 11 Medical devices & supplies companies shown. Statements: Year to Jun 30, 2025 · price Nov 20, 2026

Enterprise value
$58.13M AUD
P/E
Loss
EV/sales
1.1×
EV/EBITDA
19.6×
Price/book
2.1×
Gross margin
60.7%
Operating margin
1.4%
Net margin
−2.5%
Debt to equity
0.6×
Beta
No index for this market yet

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Compumedics Limited · ASX:CMPUS$31.07MUS$38.48Mn/a1.1×19.6×2.1×−2.5%0.6×n/a
RecensMedical, Inc. · KRX:394420US$32.60MUS$23.79Mn/a4.9×n/a2.2×−169.4%0.1×n/a
Myomo Inc. · AMEX:MYOUS$32.52MUS$32.23Mn/a0.7×n/a11.8×−33.1%4.2×2.25
Meditera Tibbi Malzeme Sanayi ve Ticaret A.S. · BIST:MEDTRUS$32.29MUS$22.70M94.9×0.4×4.0×0.5×0.6%0.0×n/a
OssDsign AB · OMXSTO:OSSDUS$32.24MUS$18.81Mn/a1.2×n/a1.2×−32.8%0.0×n/a
PuriBlood Medical Co.,Ltd. · TPEX:6847US$31.47MUS$30.71Mn/a12.3×n/a9.5×−47.4%0.1×n/a
Laseroptek Co., Ltd. · KRX:199550US$31.29MUS$18.72Mn/a0.8×n/a1.4×−22.5%0.0×n/a
TELA Bio, Inc. · NASDAQ:TELAUS$31.11MUS$64.75Mn/a0.8×n/an/a−53.6%n/a1.47
Perfect Medical Industry Co., Ltd. · TPEX:6543US$30.55MUS$26.16M18.6×1.1×7.3×1.2×7.0%0.1×n/a
Bioretec Ltd. · OMXHEX:BRETECUS$30.33MUS$17.14Mn/a4.4×n/a1.5×−269.3%0.0×n/a
Genoray Co., Ltd. · KRX:122310US$29.93MUS$17.56M15.4×0.2×3.4×0.5×2.4%0.0×n/a
Median of the othersUS$31.38MUS$23.24M18.6×1.0×4.0×1.4×−33.0%0.0×1.86

Forecasts

Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.

Price target
0.65 AUD · Analysts' mean
EPS, year to Jun 2027
0.021 · 1 analyst
Revenue, year to Jun 2027
75.6M · 1 analyst

Team and board

Officers

OfficerRole
Troy LambChief Financial Officer and Company Secretary
David BurtonExecutive Chairman
David LawsonExecutive Finance Director
Warwick FreemanChief Technology Officer

Board

DirectorRole
David BurtonExecutive Chairman
Rod NorthNon-Executive Director

Events

QuarterResultsShare move
Quarter to Dec 31, 2025Feb 26, 2026 · Before open−3.8%
Quarter to Jun 30, 2025Sep 30, 2025−1.8%
Q2 2025Feb 28, 2025−12.3%
Q2 2023Feb 28, 2023 · After close−11.1%
Q4 2022Sep 30, 2022 · After close−4.1%
Q2 2022Feb 22, 2022+7.3%
Q4 2021Aug 30, 2021+2.5%
Q2 2021Feb 24, 2021−2.2%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (November 2026)Investor deck18 slidesNov 11, 2026
Investor Presentation (November 2026)Investor deck18 slidesNovember 2026
Shareholder Meeting (October 2026)Shareholder meeting29 slidesOct 29, 2026
Shareholder Meeting (October 2026)Shareholder meeting29 slidesOct 29, 2026
FY2026 Earnings PresentationEarnings27 slidesSep 30, 2026
Investor Presentation (March 2026)Investor deck22 slidesMar 25, 2026
Investor Presentation (October 2025)Investor deck20 slidesSep 30, 2025
Investor Presentation (March 2025)Investor deck23 slidesMar 6, 2025
Investor Presentation (June 2024)Investor deck28 slidesJun 6, 2024
Bell Potter Healthcare Conference 2023Conference22 slidesNov 16, 2023
Show 50 decks
DeckKindSlidesDate
Shareholder Meeting (October 2021)Shareholder meeting26 slidesOct 28, 2021
Investor Presentation (October 2021)Investor deck24 slidesOctober 2021
Investor Presentation (August 2021)Investor deck18 slidesAug 10, 2021
Investor Presentation (March 2021)Investor deck24 slidesMarch 2021
Shareholder Meeting (November 2019)Shareholder meeting25 slidesNovember 2019
Investor Presentation (October 2019)Investor deck22 slidesOctober 2019
Investor Presentation (April 2019)Investor deck26 slidesApril 2019
Shareholder Meeting (October 2018)Shareholder meeting25 slidesOct 25, 2018
Investor Presentation (October 2018)Investor deck22 slidesOctober 2018
Investor Presentation (March 2018)Investor deck26 slidesMar 21, 2018
Shareholder Meeting (October 2017)Shareholder meeting26 slidesOctober 2017
Investor Presentation (September 2017)Investor deck22 slidesSep 5, 2017
Investor Presentation (February 2017)Investor deck24 slidesFeb 28, 2017
Shareholder Meeting (October 2016)Shareholder meeting23 slidesOct 27, 2016
Non-Deal Roadshow (September 2016)Roadshow18 slidesSeptember 2016
Non-Deal Roadshow (June 2016)Roadshow18 slidesJune 2016
Investor Presentation (April 2016)Investor deck18 slidesApr 1, 2016
Investor Presentation (February 2016)Investor deck32 slidesFeb 11, 2016
Shareholder Meeting (October 2015)Shareholder meeting34 slidesOctober 2015
Investor Presentation (September 2015)Investor deck31 slidesAug 26, 2015
Investor Presentation (May 2015)Investor deck29 slidesMay 1, 2015
Investor Presentation (May 2015)Investor deck32 slidesApr 29, 2015
Shareholder Meeting (September 2014)Shareholder meeting30 slidesSeptember 2014
Investor Presentation (March 2014)Investor deck36 slidesMar 27, 2014
Shareholder Meeting (October 2013)Shareholder meeting29 slidesOct 31, 2013
Shareholder Meeting (October 2011)Shareholder meeting19 slidesOctober 2011
H1 FY2011 Earnings PresentationEarnings12 slidesFeb 28, 2011
Non-Deal Roadshow (December 2009)Roadshow20 slidesDec 10, 2009
Investor Presentation (December 2009)Investor deck18 slidesDecember 2009
Shareholder Meeting (October 2009)Shareholder meeting39 slidesOctober 2009
Shareholder Meeting (November 2008)Shareholder meeting29 slidesNovember 2008
H1 FY2008 Earnings PresentationEarnings29 slidesFeb 27, 2008
H1 FY2008 Earnings PresentationEarnings29 slidesFeb 26, 2008
FY2007 Earnings PresentationEarnings27 slidesAug 30, 2007
Shareholder Meeting (2007)Shareholder meeting34 slides2007
Shareholder Meeting (November 2006)Shareholder meeting31 slidesNov 28, 2006
Shareholder Meeting (October 2005)Shareholder meeting25 slidesOct 28, 2005
Shareholder Meeting (October 2005)Shareholder meeting25 slidesOctober 2005
Investor Presentation (April 2005)Investor deck22 slidesApril 2005
H1 FY2005 Earnings PresentationEarnings16 slidesFeb 18, 2005

This page holds 50 of 57 decks. Open Decks

Open Decks

Financials

Annual, in AUD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue51.0M49.7M42.4M37.8M35.7M35.1M41.5M37.0M34.4M37.5M
Cost of revenue20.1M23.7M20.8M18.4M16.6M17.1M16.7M15.8M15.4M17.6M
Gross profit31.0M26.1M21.6M19.3M19.2M18.0M24.8M21.2M19.1M19.9M
Research and development1.13M5.74M5.46M4.06M4.39M3.84M5.32M5.11M5.88M5.75M
Selling, general and administrative17.4M7.08M6.41M5.64M6.12M5.93M6.01M5.48M5.64M5.26M
Operating income714.0K-812.0K-3.53M137.0K398.0K-756.0K4.54M2.58M1.42M3.21M
Depreciation and amortization2.25M1.57M1.01M1.21M1.46M1.66M428.0K482.0K1.28M1.64M
EBITDA2.96M758.0K-2.52M1.35M1.85M908.0K4.97M3.06M2.70M4.85M
Interest expense1.28M739.0K652.0K401.0K330.0K420.0K261.0K207.0K312.0K405.0K
Income before tax-593.0K480.0K-6.72M1.70M776.0K-7.50M5.09M3.49M1.11M2.81M
Income tax679.0K818.0K-597.0K341.0K-222.0K-1.67M1.07M703.0K-199.0K-467.0K
Net income-1.27M-338.0K-6.12M1.36M998.0K-5.84M4.02M2.78M1.30M3.27M
Earnings per share, basic-0.01-0.00-0.030.010.01-0.030.020.020.010.02

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents2.69M1.89M3.80M7.29M6.77M6.41M4.60M3.91M4.10M3.07M
Short-term investments00
Receivables14.9M11.1M15.0M16.5M15.5M13.6M16.0M16.2M12.9M11.7M
Inventory14.7M13.2M10.7M9.71M9.68M8.83M7.80M7.56M7.42M6.51M
Current assets35.2M26.2M29.5M33.5M31.9M28.9M30.2M29.8M25.3M22.4M
Property, plant and equipment1.78M2.95M3.62M1.21M1.71M3.08M1.65M666.0K718.0K832.0K
Total assets54.4M40.4M41.2M41.7M38.5M35.5M38.7M34.7M29.2M26.1M
Accounts payable11.7M4.37M5.26M4.74M4.45M2.93M3.10M3.91M2.94M3.02M
Current liabilities32.1M21.3M21.2M17.5M15.4M12.4M10.2M11.3M8.94M11.2M
Long-term debt0205.0K379.0K593.0K11.0K23.0K38.0K8.00K11.0K
Total debt13.9M8.58M9.47M6.55M5.82M4.80M1.59M1.89M715.0K2.58M
Total liabilities32.6M22.1M22.9M18.1M16.4M13.7M11.3M11.5M9.18M11.5M
Shareholders' equity21.8M18.2M18.3M23.6M22.2M21.8M27.3M23.2M20.1M14.6M
Shares outstanding181.7M177.2M177.2M177.2M177.2M177.2M177.2M177.2M177.2M168.8M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations681.0K2.00M49.0K3.29M1.32M5.38M5.14M559.0K864.0K2.23M
Capital spending-214.0K-2.99M-4.41M-2.98M-1.55M-4.23M-1.31M-208.0K-148.0K-304.0K
Free cash flow467.0K-986.0K-4.36M302.0K-230.0K1.15M3.82M351.0K716.0K1.93M
Cash from investing-7.37M-2.99M-4.41M-2.98M-1.55M-4.23M-4.29M-2.02M-1.29M-1.54M
Cash from financing6.10M-1.49M-1.00M1.61M-179.0K448.0K149.0K1.15M1.96M-199.0K
Dividends paid00
Share buybacks04.23M150.0K
Change in cash-556.0K-2.57M-3.50M2.15M-874.0K1.81M1.17M-198.0K1.48M569.0K

Open Financials

Filings

FilingDateTypeFiled with
Investor Update Nov-26Nov 10, 2026ResultsASX
Appointment of Strategic AdvisorNov 5, 2026Management or board changeASX
Appointment of Chief Financial Officer & Company SecretaryOct 29, 2026Management or board changeASX
Results of MeetingOct 29, 2026Meeting outcomeASX
Chair's Address to ShareholdersOct 28, 2026Other filingsASX
Appendix 4GOct 1, 2026Other filingsASX
Corporate Governance StatementOct 1, 2026Other filingsASX
Proxy FormOct 1, 2026Proxy formASX
Notice of Annual General MeetingOct 1, 2026Meeting noticeASX
Investor PresentationSep 29, 2026ResultsASX
All 136 filings
FilingDateTypeFiled with
Annual Report to shareholdersSep 29, 2026Annual reportASX
Business UpdateAug 24, 2026ResultsASX
Preliminary Final ReportAug 24, 2026ResultsASX
FY26 UpdateJul 5, 2026ResultsASX
Business Update April 2026Apr 20, 2026Operations updateASX
Half Yearly Report and AccountsFeb 24, 2026Interim reportASX
6th & New MEG OrderJan 28, 2026Other filingsASX
H1 FY25 Update - Record SalesJan 21, 2026ResultsASX
5th & New MEG OrderNov 9, 2025Operations updateASX
$2.15 Million Capital Raise for Somfit DOct 14, 2025Other filingsASX
Trading HaltOct 12, 2025Trading halt or suspensionASX
Somfit D FDASep 3, 2025Operations updateASX
Business Update FY26Aug 27, 2025ResultsASX
Preliminary Final ReportAug 27, 2025ResultsASX
Business Update Asia - $24m agreements signedJul 28, 2025Operations updateASX
FY25 Business Update - Record sales orders takenJul 13, 2025ResultsASX
New MEG orderMar 20, 2025Operations updateASX
Half Year Report and AccountsFeb 28, 2025Interim reportASX
New 5 year Somfit contract with PhilipsJan 21, 2025Operations updateASX
H1 FY25 Update - Record sales orders takenJan 14, 2025Other filingsASX
H1 FY25 Record Sales Orders takenDec 22, 2024Other filingsASX
Capital RaiseDec 4, 2024FinancingASX
Business UpdateOct 16, 2024Operations updateASX
FY2024 full year updateSep 5, 2024Other filingsASX
Europe Trading UpdateAug 5, 2024Operations updateASX
Business Update FY24Jul 15, 2024ResultsASX
PlacementJul 4, 2024FinancingASX
FY24 Business UpdateMay 22, 2024Operations updateASX
Business Update December 31Jan 10, 2024ResultsASX
$9.3m MEG sales to ChinaDec 11, 2023Operations updateASX
Pause in TradingDec 10, 2023Trading halt or suspensionASX
Somfit FDA cleared for USA marketDec 3, 2023Other filingsASX
Business Update - 30 June 2023Jul 5, 2023Operations updateASX
Half year updateFeb 28, 2023Other filingsASX
Half Year AccountsFeb 28, 2023Interim reportASX
Business Update Dec 22Jan 24, 2023Operations updateASX
Chairmans Address to ShareholdersOct 27, 2022Other filingsASX
Business Update 30 June 2022Aug 17, 2022Operations updateASX
Share buy back announcementAug 11, 2022Other filingsASX
30 June 22 Business UpdateJul 13, 2022Operations updateASX
Pre June 30 UpdateMay 27, 2022Other filingsASX
Business Update 31 Dec 21Feb 25, 2022Operations updateASX
Business Update - Dec 21Jan 11, 2022Operations updateASX
New MEG SaleJan 11, 2022Other filingsASX
Dec 8 Supplementary ReleaseDec 16, 2021Other filingsASX
Somfit Vic Gov ReleaseDec 7, 2021Other filingsASX
Business Update - June 21Aug 26, 2021Operations updateASX
Business Update - 30 June 2021Jul 18, 2021Operations updateASX
Business Update Dec 2020Jan 19, 2021Operations updateASX
30 June 20 Business UpdateAug 30, 2020Operations updateASX
30 June 20 Preliminary UpdateJul 10, 2020Other filingsASX
CoronavirusMar 23, 2020Other filingsASX
Half Year UpdateMar 1, 2020Other filingsASX
MEG FDA ApprovalFeb 16, 2020Other filingsASX
Dec 31 Business UpdateJan 12, 2020Operations updateASX
Record Revenues and Profit UpSep 1, 2019Other filingsASX
Response to ASX Price QueryJul 24, 2019Explanation requestASX
CMP MEG UpdateMay 8, 2019Other filingsASX
Major US contract winMar 20, 2019Material contractASX
China JV UpdateOct 24, 2018Other filingsASX
Change of Registry Address: Automic P/L - Sydney OfficeSep 28, 2018Other filingsASX
Revenues up 8%, NPAT up 133%Aug 29, 2018Other filingsASX
Business Up-date - June 18Jun 27, 2018Other filingsASX
Fukuda $3.6m Japan EEG Distribution ContractJun 27, 2018Other filingsASX
Somfit Strategic China DealMay 30, 2018Other filingsASX
Trading Halt RequestMay 28, 2018Trading halt or suspensionASX
$15m in new distribution contractsMay 24, 2018Other filingsASX
DWL China UpdateMay 1, 2018Other filingsASX
H1 2018 Investor PresentationMar 20, 2018Other filingsASX
S&P DJ Indices Announces March Quarterly RebalanceMar 8, 2018Other filingsASX
Business Update H1 FY18Feb 25, 2018Operations updateASX
Major European Contract WinSep 20, 2017Material contractASX
Business Performance FY17Aug 28, 2017Other filingsASX
July 2017 Business UpdateJul 6, 2017Operations updateASX
Compumedics wins major MEG ContractJun 19, 2017Other filingsASX
$3m in new orders from ChinaMay 17, 2017Other filingsASX
$2.3 China Commitment for DWLMar 2, 2017Other filingsASX
Corporate Presentation March 2017Feb 27, 2017Other filingsASX
AGM Presentation Oct 2016Oct 27, 2016Other filingsASX
Successful Capital RaiseSep 23, 2016Other filingsASX
Business Update - 30 June 2016Aug 26, 2016Operations updateASX
New $3m EEG Contract in ChinaJul 26, 2016Other filingsASX
FY16 Guidance update, continuing growth in FY17Jul 17, 2016GuidanceASX
DWL Update & MEG AppointmentJun 7, 2016Other filingsASX
Record Sales WeekApr 13, 2016Other filingsASX
$600k Perth Childrens HospitalMar 30, 2016Other filingsASX
Appendix 4E AnnualMar 30, 2016ResultsASX
German contract win based on GRAEL HD-PSG systemMar 30, 2016Material contractASX
Compumedics achieves world first brain monitoringMar 30, 2016Other filingsASX
China Update - new $1m contract wonMar 30, 2016Other filingsASX
Chairman`s Address to ShareholdersMar 30, 2016Other filingsASX
$900k boost to China businessMar 30, 2016Other filingsASX
Full Year Accounts - Appendix 4EMar 30, 2016ResultsASX
Compumedics Chinese Distributor DealMar 30, 2016Other filingsASX
New USD5m eHealth ContractMar 30, 2016Other filingsASX
Business Update - June 2104Mar 30, 2016Operations updateASX
DWL secures lucrative Brazil dealMar 30, 2016Other filingsASX
$2.0m China ContractsMar 30, 2016Other filingsASX
Half Year Report & AccountsMar 30, 2016Interim reportASX
New Neuro business and FY2013 up-dateMar 30, 2016Other filingsASX
Further Funding and New Business UpdateMar 30, 2016Operations updateASX
Funding Milestone AchievedMar 30, 2016Other filingsASX
Business Update March 2013Mar 30, 2016Operations updateASX
Appendix 4D Interim accounts 31 Dec 15Feb 24, 2016Interim reportASX
MEG Major Deal US Trade MissionFeb 21, 2016Other filingsASX
Preliminary half year guidance - on trackFeb 11, 2016GuidanceASX
US contract winFeb 10, 2016Material contractASX
Additional $1m China Sleep ContractFeb 10, 2016Other filingsASX
$2m Korean contractFeb 10, 2016Other filingsASX
Preliminary 30 June 2015 GuidanceFeb 10, 2016GuidanceASX
Record Ultrasound Contracts in GermanyFeb 10, 2016Other filingsASX
$7.5m China Sleep ContractFeb 10, 2016Other filingsASX
US Neurology Contract win - $1mFeb 10, 2016Material contractASX
Broker Presentation May 2015Feb 10, 2016Other filingsASX
New $2.2m China Neurology ContractFeb 10, 2016Other filingsASX
DWL New Patent GrantedFeb 10, 2016Other filingsASX
DWL Secures DealFeb 10, 2016Other filingsASX
New EFIC Facility in placeFeb 10, 2016Other filingsASX
eHealth USD4.1m contracts signedFeb 10, 2016Other filingsASX
Additional US Purchasing Contract WinFeb 10, 2016Material contractASX
Major contract win in the USFeb 10, 2016Material contractASX
Key European Contract WinFeb 10, 2016Material contractASX
Major Contract MilestoneFeb 10, 2016Other filingsASX
Major EEG contract winFeb 10, 2016Material contractASX
Banking refinance completedFeb 10, 2016Other filingsASX
US FDA Approves Major Product ReleaseFeb 10, 2016Other filingsASX

Open Filings

Cap table

Built by 6ix from Compumedics Limited’s releases

Common shares
199,761,754
Fully diluted
199,761,754

Fully diluted

LineShares
Common shares199,761,754

Share count over time

CountShares
Nov 22, 2026199,761,754

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
David BurtonExecutive Chairman · Since at least May 15, 2025
David LawsonExecutive Finance Director · Since at least May 15, 2025
Rod NorthNon-Executive Director · Since at least Nov 7, 2026
Troy LambChief Financial Officer and Company Secretary · Since at least Oct 29, 2026
Warwick FreemanChief Technology Officer · Since at least Nov 7, 2026

Open People

Log in to ask 6ix AI your own questions about Compumedics Limited.